4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000899243-18-004949
Chief Financial Officer sold 316 shares at $51.85 ($16,385)
From the SEC's structured data for this filing
Trades in this filing
Regnante Keith · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-02-16 | Sale : show line 1 in the form | −316 | $51.85 | $16,385 | 16,984 | D |
| Open-market sales · 316 sh · avg $51.85 · $16,385 | ||||||
Loading xslF345X03/doc4.xml…